Pulmonary arterial hypertension in collagen disease: Findings of the German Network for Systemic Scleroderma;Pulmonalarterielle hypertonie bei kollagenosen - Erfahrungen aus dem Deutschen Netzwerk für Systemische Sklerodermie

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 49 SUPPL. 9, 2006, Pages

  Hunzelmann, Nicolas ^a   Riemekasten, G ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CYCLOPHOSPHAMIDE; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN;

COLLAGEN DISEASE; ECHOCARDIOGRAPHY; GERMANY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; PULMONARY HYPERTENSION; REVIEW; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

EID: 33846316031     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957203     Document Type: Review

References (5)

1. Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3698-3700
2. Mukerjee D, St George D, Coleiro B et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-1093
3. Pope JE, Lee P, Baron M et al. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 2005; 32: 1273-1278
4. Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005; 52: 2125-2132
5. Tashkin DP, Elashoff R, Clements PJ et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med (United States) 2006; 354: 2655-2566